## **Core Concept**
Torsades de pointes (TdP) is a specific type of abnormal heart rhythm that can be life-threatening. It is a form of polymorphic ventricular tachycardia characterized by a long QT interval on the electrocardiogram (ECG). The management of TdP focuses on correcting the underlying cause, particularly addressing the long QT interval, and ensuring hemodynamic stability.

## **Why the Correct Answer is Right**
The drug of choice for torsades de pointes is **Magnesium sulfate**. Magnesium plays a critical role in stabilizing cardiac membranes and is effective in treating TdP by reducing the risk of further arrhythmic events. It works quickly to shorten the QT interval and can be administered intravenously, making it suitable for acute management. The effectiveness of magnesium sulfate in TdP is well-established, and it is often recommended as a first-line treatment.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because, although it might seem plausible, it is not the correct choice for the treatment of torsades de pointes.
- **Option B:** This option is incorrect as it does not represent the drug of choice for TdP.
- **Option C:** While this might seem like a potential treatment, it is not the first-line or preferred treatment for torsades de pointes.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that in the setting of torsades de pointes, **magnesium sulfate** is administered intravenously, and if the patient is also hypokalemic or hypomagnesemic, these electrolytes should be supplemented. Additionally, any offending medications that may be prolonging the QT interval should be discontinued.

## **Correct Answer:** . **Magnesium sulfate**